Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer's Disease and Mild Cognitive Impairment patients
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 357, 577561
Abstract
No abstract availableKeywords
Funding Information
- European Social Fund Plus (MIS 5047901)
- European Commission (MIS 5047901)
This publication has 106 references indexed in Scilit:
- Induction of COX-2 Enzyme and Down-regulation of COX-1 Expression by Lipopolysaccharide (LPS) Control Prostaglandin E2 Production in AstrocytesJournal of Biological Chemistry, 2012
- Inflammation Induced by Infection Potentiates Tau Pathological Features in Transgenic MiceThe American Journal of Pathology, 2011
- Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteriaJournal of Neuroinflammation, 2011
- Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implicationsBiochimie, 2011
- Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)Journal of Neuroimmunology, 2009
- Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generationJournal of Neuroinflammation, 2008
- Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniaeBMC Neuroscience, 2008
- Genetic deletion or pharmacological inhibition of cyclooxygenase‐1 attenuate lipopolysaccharide‐ induced inflammatory response and brain injuryThe FASEB Journal, 2007
- Physiologic and pathophysiologic roles of lipid mediators in the kidneyKidney International, 2007
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984